Boule Diagnostics AB (publ) (BOUL.ST) Research

Boule Diagnostics AB (publ) operates as a diagnostic company specializing in the development, manufacturing, and commercialization of instruments and consumables designed for blood analysis. Its comprehensive product portfolio for human diagnostics includes a range of hematology analyzers, reagents, blood controls and calibrators, reagent rotors, and cleaning products, distributed under the Swelab, Medonic, and Quintus brand names. Furthermore, it provides veterinary hematology and clinical chemistry analyzer and diagnostic systems through its Exigo brand. Distribution is handled directly in Sweden and the United States, complemented by an international network of distributors. Boule serves a diverse client base encompassing hospitals, clinical laboratories, healthcare centers, veterinary clinics, and other diagnostic companies. The company maintains operational presences in Sweden, the United States, Mexico, and Russia. Established in 1956, Boule Diagnostics AB is headquartered in Spånga, Sweden.

Market snapshot

Symbol
BOUL.ST
Price
$3.20
Day change
-3.03%
Market cap
$124.3M
P/E ratio
-15.24x
52-week range
3.09-10.6
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 25 days

Peer companies

  • Acarix AB (publ) (ACARIX.ST)
  • AlzeCure Pharma AB (publ) (ALZCUR.ST)
  • BrainCool AB (publ) (BRAIN.ST)
  • Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
  • Integrum AB (publ) (INTEG-B.ST)
  • IRLAB Therapeutics AB (publ) (IRLAB-A.ST)
  • Karolinska Development AB (publ) (KDEV.ST)
  • Mentice AB (publ) (MNTC.ST)

Open Boule Diagnostics AB (publ) (BOUL.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.